
CASI PHARMACEUTICALS INC by CASI Pharmaceuticals fell 92.8% from $1.38 to $0.10, behind the S&P 500's +9.8%. Its worst day was Feb 25 (−74.1%), and its low came Oct 13 at $0.10.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
CASI PHARMACEUTICALS INC by CASI Pharmaceuticals closed at its highest level of the year, 5.1% above where the year started.
+5.1% · S&P 500 +0.1%
CASI PHARMACEUTICALS INC by CASI Pharmaceuticals shares fell 74.1%, while the S&P 500 rose 0.8%.
Story events cover the past 12 months · Times ET
−74.1%, the year's worst day, on 10M shares, the year's heaviest volume · S&P 500 +0.8%
CASI PHARMACEUTICALS INC by CASI Pharmaceuticals shares fell 35.7%, while the S&P 500 fell 0.2%.
−35.7% · S&P 500 −0.2%
CASI PHARMACEUTICALS INC by CASI Pharmaceuticals shares rose 41.5%, while the S&P 500 fell 0.3%.
+41.5% · S&P 500 −0.3%
CASI PHARMACEUTICALS INC by CASI Pharmaceuticals shares rose 42.9%, while the S&P 500 rose 0.5%.
+42.9%, the year's best day · S&P 500 +0.5%
CASI PHARMACEUTICALS INC by CASI Pharmaceuticals shares rose 41.2%, while the S&P 500 fell 0.1%.
+41.2% · S&P 500 −0.1%
CASI PHARMACEUTICALS INC by CASI Pharmaceuticals shares rose 33.5%, while the S&P 500 fell 0.8%.
+33.5% · S&P 500 −0.8%
CASI PHARMACEUTICALS INC by CASI Pharmaceuticals closed at its lowest level of the year, 92.8% below where the year started.
−4.9% · S&P 500 0.0%
Where it ended: a close of $0.10 on Nov 10, 2026.
Nothing in the past 12 months.
All CASIF earningsNothing in the past 12 months.
All CASIF analyst actionsNothing in the past 12 months.
All CASIF dividend historyNothing in the past 12 months.
All CASIF news